Katarina Luptakova
2023
In 2023, Katarina Luptakova earned a total compensation of $932.2K as Chief Medical Officer at Xilio Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $156,240 |
|---|---|
| Option Awards | $340,253 |
| Salary | $421,667 |
| Other | $14,010 |
| Total | $932,170 |
Luptakova received $421.7K in salary, accounting for 45% of the total pay in 2023.
Luptakova also received $156.2K in non-equity incentive plan, $340.3K in option awards and $14K in other compensation.
Rankings
In 2023, Katarina Luptakova's compensation ranked 1,220th out of 2,647 executives tracked by ExecPay. In other words, Luptakova earned more than 53.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,220 out of 2,647 | 54th |
Division Manufacturing | 729 out of 1,447 | 50th |
Major group Chemicals And Allied Products | 486 out of 817 | 41st |
Industry group Drugs | 474 out of 783 | 40th |
Industry Pharmaceutical Preparations | 323 out of 555 | 42nd |
Source: SEC filing on April 25, 2024.
Luptakova's colleagues
We found three more compensation records of executives who worked with Katarina Luptakova at Xilio Therapeutics in 2023.